|
Home Ā» Briefs Ā» State of Iowa v. Abbott Laboratories, et al.

Services

Econ One’s expert economists have experience across a wide variety of services including antitrust, class certification, damages, financial markets and securities, intellectual property, international arbitration, labor and employment, and valuation and financial analysis.

Resources

Econ One’s resources including blogs, cases, news, and more provide a collection of materials from Econ One’s experts.

Cases and Engagements
Get an Inside look at Economics with the experts.
Managing Director
Education

Ph.D. in Economics, University of California, Los Angeles

M.A. in Economics, University of California, Los Angeles

B.S. in Economics, Santa Clara University

Econ One, President, 1997 ā€“ Present

Founded Econ One, 1997

Micronomics, Inc., President and CEO, 1994 ā€“ 1997

Micronomics, Inc., Executive Vice President, 1988 ā€“ 1997

Cofounded Micronomics, Inc., 1988

National Economic Research Associates, Inc. (Last position was Senior Vice President and member of the Board of Directors) 1980 ā€“ 1988

U.S. District Court

U.S. Bankruptcy Court

State Court

Federal Energy Regulatory Commission

Various state tax and regulatory commissions

Private arbitration

International Arbitration

Share this Article
September 30, 2015

State of Iowa v. Abbott Laboratories, et al.

Average Wholesale Price (ā€œAWPā€) serves as a benchmark from which state Medicaid programs reimburse pharmacies for providing pharmaceuticals to Medicaid participants.Ā  The plaintiffs allege that pharmaceutical manufacturers routinely inflated the AWPs they reported to trade publications, causing the plaintiffs to overpay for Medicaid reimbursements.

Econ One was retained by counsel for the plaintiffs.Ā  Jeffrey Leitzinger submitted multiple expert reports analyzing the Medicaid reimbursements made by the plaintiffs. Dr. Leitzinger also provided deposition testimony. The case (State of Iowa v. Abbott Laboratories, et al. case 4:2007cv00461) settled prior to trial.

Services: Antitrust
Industries: Pharmaceutical, Healthcare
Latest Related Resources and Insights